We further evaluated the clinicopathological significance of BEST4 expression in CRC patients by examining its correlation with gender, tumour-node-metastases stage, and lymph node metastasis based on the eighth edition of the American Joint Committee on Cancer Staging Manual (Amin, 2017). The gene discussed is BEST4; the disease is colorectal carcinoma.